Searched for
CHINA DRUG PROCUREMENT
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
Different packaging, typos expose fake Mounjaro racketGurugram authorities uncovered a counterfeit Mounjaro operation. Police seized fake diabetes and weight loss injections valued at ₹70 lakh....
Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in ChinaIndian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health mi...
China to 'refine' centralized medicine procurement policiesChina will refine its centralized drug procurement policy following a probe into off-patent medicine quality, aiming to enhance evaluations...
China bars GSK from bulk-buy drug programme for 18 monthsFirst reported by CCTV state television, the ban was imposed by authorities after a batch of GSK's prostate treatment - known chemically as...
Hyderabad pharmaceutical Raghava Life Sciences gets nod to make Favipiravir APIThe Hyderabad-based producer of active pharmaceutical ingredients (APIs) had in May commercialised the Favipiravir API and is currently dis...
Industry fears Trump's 'Buy American' order may hurt India's pharmaceutical companiesTrump's buy-American plan calls for US agencies to increase procurement by limiting competition to those essential medicines, medical count...
Indian API makers benefit as global buyers ditch ChinaPrice sensitivity among formulation companies is declining amid a receding threat of supply chain disruptions from Chinese suppliers, which...
BMC to acquire 20,000 doses of Tocilizumab even as trials yet to determine efficacyThe health ministry has also recommended tocilizumab in its national clinical guidelines, which say the drug may be considered for patients...
Some companies still have the licence to import faulty antibody kitsMore than a dozen importers continue to hold licences to buy coronavirus antibody test kits from two Chinese companies that the Indian Coun...
Sun Pharma flags hypertension drug shortageIndian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs)...
India calls for 'clear roadmap' from China to ramp up Indian pharmaceutical exportsBesides pharmaceuticals, India has been asking China to open up its IT market as well to ensure steady increase of Indian exports.
Strategy in the works to woo companies looking to exit ChinaThe core of the idea was increasing exports to China & reducing imports by local manufacturing.
China stocks slide as healthcare, energy firms tumbleAt 07:16 GMT, the yuan was quoted at 6.895 per US dollar.
Pharma stocks slip on fears of US clamp downBulk drugs, or active pharmaceutical ingredients (APIs), are the ingredients used to give a drug its therapeutic effect.
Policy lethargy must end to hold drug prices downA superior option is for the government to impose price controls on expensive drugs, whether imported or produced domestically.
- Non-tariff barriers hit drug exports to China
Non-tariff barriers in the form of procedural, legal and cultural barriers are a major deterrent to Indian pharmaceutical exports to China,...
- 'Non-tariff barriers stump pharma exports to China'
Industry body FICCI has asked the government to remove non-tariff barriers to enable the country's pharmaceuticals exports to make a signif...